Proactive - Interviews for investors
Poolbeg Pharma: Sites ready, data due this summer — and Big Pharma is starting to knock
Poolbeg Pharma CEO Jeremy Skillington provides an update on the company's clinical trials. He discusses the POLB-001 trial, with interim data expected this summer, and progress on an oral GLP-1 program.